|By PR Newswire||
|September 3, 2014 01:00 PM EDT||
SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Morgan Stanley Global Healthcare Conference in New York City.
The live presentation takes place on Wednesday, September 10 at 11:30am ET (8:30am PT). The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.
Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.
Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.
"We are a custom software development, engineering firm. We specialize in cloud applications from helping customers that have on-premise applications migrating to the cloud, to helping customers design brand new apps in the cloud. And we specialize in mobile apps," explained Peter Di Stefano, Vice President of Marketing at Impiger Technologies, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 10, 2016 12:30 AM EST Reads: 585
Dec. 9, 2016 11:30 PM EST Reads: 1,147
Dec. 9, 2016 10:45 PM EST Reads: 516
Dec. 9, 2016 10:30 PM EST Reads: 1,717
Dec. 9, 2016 10:00 PM EST Reads: 301
Dec. 9, 2016 09:45 PM EST Reads: 2,006
Dec. 9, 2016 09:30 PM EST Reads: 1,283
Dec. 9, 2016 08:00 PM EST Reads: 1,023
Dec. 9, 2016 07:45 PM EST Reads: 727
Dec. 9, 2016 06:45 PM EST Reads: 5,148
Dec. 9, 2016 06:15 PM EST Reads: 1,767
Dec. 9, 2016 05:30 PM EST Reads: 2,375
Dec. 9, 2016 05:15 PM EST Reads: 1,472
Dec. 9, 2016 05:15 PM EST Reads: 424
Dec. 9, 2016 05:15 PM EST Reads: 1,891